Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A for brain injury in hypertensive cerebral hemorrhage
NCT04509323Phase 4Unknown
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Huperzine A in hypertensive intracerebral hemorrhage (HICH), sponsored by Jiangsu Famous Medical Technology. Status: unknown.
02
Drugs
Huperzine A
03
Conditions
hypertensive intracerebral hemorrhage (HICH)
Beyond the preview
Go deeper on NCT04509323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509323.